Thromboprophylaxis and Its Implications in Regional Anesthesia

Venous Thromboembolism (VTE) is an important cause of postoperative morbidity and mortality, especially when patients with co-morbid conditions (like obesity, coronary artery disease, or cancer) are on the rise. This necessitates the use of various thromboprophylaxis measures to prevent the occurrences of fatal VTE. However, the pharmacological thromboprophylaxis carries an inherent risk of bleeding, especially when the area of invasive work involves a potential space with risk of non-compressible arterial puncture. During neuraxial anesthesia, such bleeding into a closed space can result in spinal hematoma, which carries various neurological sequelae and requires urgent diagnosis and management. We will be discussing the relevant literature pertaining to the modalities of thromboprophylaxis, their mechanism of action and optimal management of such patients in the perioperative setting.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-01-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.15226/2374-684X/5/1/00154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol

  2017cited by this paper
• Neuraxial Anesthesia in Obstetric Patients Receiving Thromboprophylaxis With Unfractionated or Low-Molecular-Weight Heparin: A Systematic Review of Spinal Epidural Hematoma

  2017cited by this paper
• Thromboprophylaxis Failure in the Adult Medical Inpatient☆

  2017cited by this paper
• Anticoagulant induced spontaneous spinal epidural hematoma, conservative management or surgical intervention—A dilemma?

  2016cited by this paper
• Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

  2015cited by this paper
• Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients*

  2015cited by this paper
• Epidurals in Patients Receiving Thromboprophylaxis with Unfractionated Heparin Three Times a Day: The Value of Activated Partial Thromboplastin Time Testing

  2014cited by this paper
• Pharmacological thromboprophylaxis and epidural anaesthesia

  2012influential reference
• Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Venous thromboembolism: risks and prevention

  2011influential reference
• Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy.

  2011cited by this paper
• Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)

  2009cited by this paper
• Guideline : Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

  2007cited by this paper
• Thrombosis risk assessment as a guide to quality patient care.

  2005cited by this paper
• Thromboprophylaxis in surgical patients.

  2003influential reference
• Local and Regional Anesthesia Dovepress Neuraxial and Peripheral Nerve Blocks in Patients Taking Anticoagulant or Thromboprophylactic Drugs: Challenges and Solutions

  year unknowncited by this paper

• No citing papers are available for this paper.